Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LASERLESS: Aflibercept and Endolaserless Vitrectomy for PDR
NCT02976012Phase 2Unknown
- Sponsor
- Southeast Retina Center
- Start
- Jun 2016
- Primary completion
- Jun 2018
- Modality
- Engineered Antibody Formats, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of aflibercept in proliferative diabetic retinopathy (PDR), sponsored by Southeast Retina Center. Status: unknown.
02
Drugs
aflibercept
03
Conditions
proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on NCT02976012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02976012.